BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: Navigating the unknown in search of function. J Biol Chem. 2017;292:8553-8559. [PMID: 28389566 DOI: 10.1074/jbc.r116.752899] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Ansari A, Bose S, You Y, Park S, Kim Y. Molecular Mechanism of Microbiota Metabolites in Preterm Birth: Pathological and Therapeutic Insights. Int J Mol Sci 2021;22:8145. [PMID: 34360908 DOI: 10.3390/ijms22158145] [Reference Citation Analysis]
2 Shaligram S, Narwade NP, Kumbhare SV, Bordoloi M, Tamuli KJ, Nath S, Parimelazhagan T, Patil VS, Kapley A, Pawar SP, Dhotre DP, Muddeshwar MG, Purohit HJ, Shouche YS. Integrated Genomic and Functional Characterization of the Anti-diabetic Potential of Arthrobacter sp. SW1. Curr Microbiol 2021;78:2577-88. [PMID: 33983483 DOI: 10.1007/s00284-021-02523-8] [Reference Citation Analysis]
3 Wu K, Yuan Y, Yu H, Dai X, Wang S, Sun Z, Wang F, Fei H, Lin Q, Jiang H, Chen T. The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. Blood 2020;136:501-15. [PMID: 32291445 DOI: 10.1182/blood.2019003990] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 34.0] [Reference Citation Analysis]
4 Ephraim E, Cochrane CY, Jewell DE. Varying Protein Levels Influence Metabolomics and the Gut Microbiome in Healthy Adult Dogs. Toxins (Basel) 2020;12:E517. [PMID: 32806674 DOI: 10.3390/toxins12080517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Int J Biol Sci 2021;17:818-33. [PMID: 33767591 DOI: 10.7150/ijbs.56214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Peralta-Marzal LN, Prince N, Bajic D, Roussin L, Naudon L, Rabot S, Garssen J, Kraneveld AD, Perez-Pardo P. The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders. Int J Mol Sci 2021;22:10052. [PMID: 34576216 DOI: 10.3390/ijms221810052] [Reference Citation Analysis]
7 Cruz-Lebrón A, Johnson R, Mazahery C, Troyer Z, Joussef-Piña S, Quiñones-Mateu ME, Strauch CM, Hazen SL, Levine AD. Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity. Gut Microbes 2021;13:1946368. [PMID: 34313547 DOI: 10.1080/19490976.2021.1946368] [Reference Citation Analysis]
8 Tsalgatidou PC, Thomloudi E, Baira E, Papadimitriou K, Skagia A, Venieraki A, Katinakis P. Integrated Genomic and Metabolomic Analysis Illuminates Key Secreted Metabolites Produced by the Novel Endophyte Bacillus halotolerans Cal.l.30 Involved in Diverse Biological Control Activities. Microorganisms 2022;10:399. [DOI: 10.3390/microorganisms10020399] [Reference Citation Analysis]
9 Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. J Exp Med 2019;216:41-59. [PMID: 30385457 DOI: 10.1084/jem.20180794] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 22.0] [Reference Citation Analysis]
10 Carbonero F. Human epigenetics and microbiome: the potential for a revolution in both research areas by integrative studies. Future Sci OA 2017;3:FSO207. [PMID: 28884004 DOI: 10.4155/fsoa-2017-0046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Desselberger U. The Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy. Pathogens 2018;7:E57. [PMID: 29933546 DOI: 10.3390/pathogens7030057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
12 Vernocchi P, Del Chierico F, Putignani L. Gut Microbiota Metabolism and Interaction with Food Components. Int J Mol Sci 2020;21:E3688. [PMID: 32456257 DOI: 10.3390/ijms21103688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
13 Sudhakar P, Machiels K, Verstockt B, Korcsmaros T, Vermeire S. Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions.Front Microbiol. 2021;12:618856. [PMID: 34046017 DOI: 10.3389/fmicb.2021.618856] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Javed I, Zhang Z, Adamcik J, Andrikopoulos N, Li Y, Otzen DE, Lin S, Mezzenga R, Davis TP, Ding F, Ke PC. Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC. Adv Sci (Weinh) 2020;7:2001299. [PMID: 32999841 DOI: 10.1002/advs.202001299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Park H, Jin UH, Karki K, Jayaraman A, Allred C, Michelhaugh SK, Mittal S, Chapkin RS, Safe S. Dopamine is an aryl hydrocarbon receptor agonist. Biochem J 2020;477:3899-910. [PMID: 32905582 DOI: 10.1042/BCJ20200440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Durán-Maldonado MX, Hernández-Padilla L, Gallardo-Pérez JC, Díaz-Pérez AL, Martínez-Alcantar L, Reyes De la Cruz H, Rodríguez-Zavala JS, Pacheco-Rodríguez G, Moss J, Campos-García J. Bacterial Cyclodipeptides Target Signal Pathways Involved in Malignant Melanoma. Front Oncol 2020;10:1111. [PMID: 32793477 DOI: 10.3389/fonc.2020.01111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Skrzypecki J, Izdebska J, Kamińska A, Badowska J, Przybek-Skrzypecka J, Bombuy J, Samborowska E, Szaflik JP. Glaucoma patients have an increased level of trimethylamine, a toxic product of gut bacteria, in the aqueous humor: a pilot study. Int Ophthalmol 2021;41:341-7. [PMID: 32914277 DOI: 10.1007/s10792-020-01587-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Sharpton SR, Schnabl B, Knight R, Loomba R. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. Cell Metab 2021;33:21-32. [PMID: 33296678 DOI: 10.1016/j.cmet.2020.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Xie Y, Hu X, Li S, Qiu Y, Cao R, Xu C, Lu C, Wang Z, Yang J. Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106161] [Reference Citation Analysis]
20 Linninge C, Roth B, Erlanson-Albertsson C, Molin G, Toth E, Ohlsson B. Abundance of Enterobacteriaceae in the colon mucosa in diverticular disease. World J Gastrointest Pathophysiol 2018; 9(1): 18-27 [PMID: 29487763 DOI: 10.4291/wjgp.v9.i1.18] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
21 Sharpton SR, Ajmera V, Loomba R. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol 2019;17:296-306. [PMID: 30196156 DOI: 10.1016/j.cgh.2018.08.065] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
22 Shen YF, Hu Y, Zhu B, Wang GX. Antiviral activity of anisomycin against spring viraemia of carp virus in epithelioma papulosum cyprini cells and zebrafish. Virus Res 2019;268:38-44. [PMID: 31136824 DOI: 10.1016/j.virusres.2019.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 McGinniss JE, Whiteside SA, Simon-Soro A, Diamond JM, Christie JD, Bushman FD, Collman RG. The lung microbiome in lung transplantation. J Heart Lung Transplant 2021;40:733-44. [PMID: 34120840 DOI: 10.1016/j.healun.2021.04.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Banerjee R. Introduction to the Thematic Minireview Series: Host-microbiome metabolic interplay. J Biol Chem 2017;292:8544-5. [PMID: 28389560 DOI: 10.1074/jbc.R117.786137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
25 Ailioaie LM, Litscher G. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges. Int J Mol Sci 2021;22:4942. [PMID: 34066560 DOI: 10.3390/ijms22094942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Healy AR, Herzon SB. Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective. J Am Chem Soc 2017;139:14817-24. [PMID: 28949546 DOI: 10.1021/jacs.7b07807] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
27 Ortega MA, Alvarez-Mon MA, García-Montero C, Fraile-Martinez O, Guijarro LG, Lahera G, Monserrat J, Valls P, Mora F, Rodríguez-Jiménez R, Quintero J, Álvarez-Mon M. Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications. Metabolites 2022;12:50. [PMID: 35050172 DOI: 10.3390/metabo12010050] [Reference Citation Analysis]
28 Schepis T, De Lucia SS, Nista EC, Manilla V, Pignataro G, Ojetti V, Piccioni A, Gasbarrini A, Franceschi F, Candelli M. Microbiota in Pancreatic Diseases: A Review of the Literature. J Clin Med 2021;10:5920. [PMID: 34945216 DOI: 10.3390/jcm10245920] [Reference Citation Analysis]
29 Sharpton SR, Yong GJM, Terrault NA, Lynch SV. Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease. Hepatol Commun 2019;3:29-43. [PMID: 30619992 DOI: 10.1002/hep4.1284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
30 Taylor SA, Green RM. Bile Acids, Microbiota, and Metabolism. Hepatology 2018;68:1229-31. [PMID: 29729182 DOI: 10.1002/hep.30078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
31 Pintus R, Bassareo PP, Dessì A, Deidda M, Mercuro G, Fanos V. Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine. Biomed Res Int 2017;2017:6970631. [PMID: 28758121 DOI: 10.1155/2017/6970631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
32 Jackson MI, Waldy C, Jewell DE. Dietary resistant starch preserved through mild extrusion of grain alters fecal microbiome metabolism of dietary macronutrients while increasing immunoglobulin A in the cat. PLoS One 2020;15:e0241037. [PMID: 33141838 DOI: 10.1371/journal.pone.0241037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Desselberger U. Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases. Viruses 2021;13:1601. [PMID: 34452466 DOI: 10.3390/v13081601] [Reference Citation Analysis]
34 Dong LN, Wang M, Guo J, Wang JP. Role of intestinal microbiota and metabolites in inflammatory bowel disease. Chin Med J (Engl) 2019;132:1610-4. [PMID: 31090547 DOI: 10.1097/CM9.0000000000000290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Han R, Ma J, Li H. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Front Med. 2018;12:645-657. [PMID: 30178233 DOI: 10.1007/s11684-018-0645-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
36 Xu P, Lv T, Dong S, Cui Z, Luo X, Jia B, Jeon CO, Zhang J. Association between intestinal microbiome and inflammatory bowel disease: insights from bibliometric analysis. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.04.006] [Reference Citation Analysis]
37 Wan L, Zhou X, Wang C, Chen Z, Peng H, Hou X, Peng Y, Wang P, Li T, Yuan H, Shi Y, Hou X, Xu K, Xie Y, He L, Xia K, Tang B, Jiang H. Alterations of the Gut Microbiota in Multiple System Atrophy Patients. Front Neurosci 2019;13:1102. [PMID: 31680836 DOI: 10.3389/fnins.2019.01102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
38 Xu M, Yang K, Zhu J. Monitoring the Diversity and Metabolic Shift of Gut Microbes during Green Tea Feeding in an In Vitro Human Colonic Model. Molecules 2020;25:E5101. [PMID: 33153091 DOI: 10.3390/molecules25215101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Amedei A, Morbidelli L. Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function. Molecules 2019;24:E3992. [PMID: 31694161 DOI: 10.3390/molecules24213992] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
40 Ansari A, Lee H, You YA, Jung Y, Park S, Kim SM, Hwang GS, Kim YJ. Identification of Potential Biomarkers in the Cervicovaginal Fluid by Metabolic Profiling for Preterm Birth. Metabolites 2020;10:E349. [PMID: 32867268 DOI: 10.3390/metabo10090349] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]